Lobbying client

YAMO PHARMACEUTICALS, LLC

Pharmaceutical company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
7
Filed by
2
Reported in-house
—
Reported by firms
$180,000

Filings

7 filings, newest first.
Filing Filed by Amount
3rd Quarter - Amendment
3rd Quarter 2018
BROWNSTEIN HYATT FARBER SCHRECK, LLP $80,000 reported
4th Quarter - Termination (No Activity)
4th Quarter 2018
BROWNSTEIN HYATT FARBER SCHRECK, LLP — reported
3rd Quarter - Reportreplaced
3rd Quarter 2018
BROWNSTEIN HYATT FARBER SCHRECK, LLP $80,000 reported
Registration
3rd Quarter 2018
BROWNSTEIN HYATT FARBER SCHRECK, LLP — reported
2nd Quarter - Termination
2nd Quarter 2018
BAKER & HOSTETLER LLP $50,000 reported
1st Quarter - Report
1st Quarter 2018
BAKER & HOSTETLER LLP $50,000 reported
Registration
1st Quarter 2018
BAKER & HOSTETLER LLP — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
BAKER & HOSTETLER LLP 2 $100,000
BROWNSTEIN HYATT FARBER SCHRECK, LLP 2 $80,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 3
Pharmacy PHA 2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.